Kwikheal Tablet

The enzymatic action of Trypsin and Chymotrypsin enhances microcirculation and supports the resolution of hematomas and exudates. This medication is commonly prescribed as an adjunct to conventional therapy in conditions such as sprains, strains, contusions, and postoperative inflammation. Kwikheal Tablet should be used under medical supervision, with dosage tailored according to the severity of the condition and patient response.

It is contraindicated in individuals with hypersensitivity to proteolytic enzymes, active bleeding disorders, or peptic ulcers. Caution is advised in patients with coagulation abnormalities or those on anticoagulant therapy. Adverse effects are rare but may include gastrointestinal discomfort or allergic reactions. Overall, Kwikheal Tablet is a valuable therapeutic agent in managing inflammatory and edematous conditions to promote faster recovery.